Study Stopped
Application for regulatory approval withdrawn
Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP
Pulmonary Mechanics in Preterm Infants Treated With Heated Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure.
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study is designed to evaluate the effect of heated humidified high flow nasal cannula (HHHFNC) as compared to noninvasive nasal continuous positive airway pressure (NCPAP) on lung function as a measure of lung injury in preterm infants born at 28 to 37 weeks gestation requiring continuing respiratory support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2013
CompletedFirst Posted
Study publicly available on registry
September 11, 2013
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedSeptember 15, 2015
September 1, 2015
Same day
August 30, 2013
September 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulmonary mechanics and chest wall asynchrony measures.
Pulmonary mechanics measures consisting of dynamic lung compliance, airway resistance, and work of breathing and chest wall asynchrony measures consisting of thoracoabdominal asynchrony, labored breathing index and rib cage to abdominal phase relation during the total breath are measured in preterm infants treated with HHHFNC and compared to the same measurements in preterm infants treated with NCPAP.
2 years
Secondary Outcomes (3)
Duration of respiratory support or oxygen use up to the time of discharge from the NICU.
2 years
The incidence of potential adverse outcomes associated with HHHFNC or NCPAP.
2 years
Time needed to establish full enteral feeds
2 years
Study Arms (2)
HHHFNC
OTHERTreatment of respiratory distress by Heated Humidified High Flow Nasal Cannula (HHHFNC). Escalation of the ventilatory support per protocol and the attending physician.
NCPAP
OTHERTreatment of respiratory distress by nasal continuous positive airway pressure (NCPAP). Escalation of the ventilatory support per protocol and the attending physician.
Interventions
Biweekly measurement of lung mechanics (dynamic compliance, airway resistance, work of breathing) and chest wall asynchrony measures while on HHHFNC and weekly when weaned off until 40 weeks post conceptional age or discharge. Recording of the level and the type of respiratory support and all cross over respiratory support devices. Recording of all growth parameters, neonatal morbidities and therapies.
Biweekly measurement of lung mechanics (dynamic compliance, airway resistance, work of breathing) and chest wall asynchrony measures while on NCPAP and weekly when weaned off until 40 weeks post conceptional age or discharge. Recording of the level and the type of respiratory support and all cross over respiratory support devices. Recording of all growth parameters, neonatal morbidities and therapies.
Eligibility Criteria
You may qualify if:
- Birth weight greater than or equal to 1000 grams.
- Gestational age at birth between 28 weeks and 37 weeks (28 0/7 to 37 6/7 weeks inclusive).
- Candidate for non-invasive respiratory support as a result of:
- An intention to manage the infant with non-invasive (no endotracheal tube) respiratory support.
- An intention to extubate an infant being managed with intubated respiratory support to non-invasive respiratory support.
- Subjects must have a guardian or acceptable surrogate capable of giving consent on his/her behalf.
You may not qualify if:
- Birth weight less than 1000 grams.
- Estimated gestation at birth less than 28 weeks or greater than 37 6/7 weeks.
- Active air leak syndrome.
- Subjects will not be eligible if they are not considered viable.
- Infants with abnormalities of the upper and lower airways
- Infants with significant abdominal or respiratory malformations .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pennsylvania Hospital
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Soraya Abbasi, MD
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2013
First Posted
September 11, 2013
Study Start
March 1, 2014
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
September 15, 2015
Record last verified: 2015-09